Travere Therapeutics (NASDAQ: TVTX) Gains Analyst Confidence Amidst New Kidney Disease Drug Partnership
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameTravere Therapeutics Inc (formerly Retrophin Inc)
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









